Holistic care in inflammatory bowel disease: is it in REACH? - Scorecard - MDSpire

Holistic care in inflammatory bowel disease: is it in REACH?

  • By

  • Hyder Said

  • Calum D Moulton

  • Ailsa Hart

  • Laurie Keefer

  • January 27, 2026

  • 0 min

Share

Clinical Scorecard: Integrative Approaches to Managing Inflammatory Bowel Disease: Are They Attainable?

At a Glance

CategoryDetail
ConditionInflammatory Bowel Disease (IBD), including Crohn’s disease and ulcerative colitis
Key MechanismsChronic immune-mediated gastrointestinal inflammation with persistent symptoms including abdominal pain, fatigue, urgency, sleep disturbances, mood disorders, and extra-intestinal manifestations
Target PopulationIndividuals diagnosed with IBD experiencing both inflammatory and non-inflammatory symptoms
Care SettingMultidisciplinary and holistic care models within IBD centers, community-based programs, and integrated medical homes

Key Highlights

  • Multidisciplinary teams including gastroenterologists, psychologists, nurses, and dieticians improve comprehensive care for IBD.
  • Persistent symptoms such as chronic abdominal pain, fatigue, and sleep disturbances significantly impact quality of life despite mucosal healing.
  • Holistic care models address both inflammatory and non-inflammatory symptoms, incorporating behavioral modifications and mental health interventions.

Guideline-Based Recommendations

Diagnosis

  • Conduct thorough assessment of symptom burden beyond inflammation, including extra-intestinal manifestations and psychological comorbidities.
  • Evaluate chronic abdominal pain considering neuropathic and nociplastic mechanisms.
  • Assess fatigue and sleep disturbances as part of routine clinical evaluation.

Management

  • Implement multidisciplinary, holistic care integrating medical, psychological, and allied health interventions.
  • Use antidepressant medications to restore gut–brain axis function and improve mental and physical symptoms.
  • Address health behaviors such as nutrition, smoking cessation, and stress management to influence disease activity.

Monitoring & Follow-up

  • Ongoing evaluation of symptom burden and quality of life to guide personalized interventions.
  • Monitor treatment side effects and adjust combination therapies accordingly.
  • Utilize digital health technologies to enhance longitudinal, patient-centered care.

Risks

  • Persistent symptoms despite mucosal healing may lead to increased healthcare utilization and reduced quality of life.
  • Underrecognition and poor standardization in managing extra-intestinal manifestations can worsen outcomes.
  • Psychological comorbidities and sleep disturbances contribute to fatigue and symptom persistence.

Patient & Prescribing Data

Patients with IBD experiencing persistent symptoms including mood disorders and chronic pain

Antidepressants can concurrently improve gut–brain axis function, mental health, and physical symptoms; dosing and side-effect profiles require careful management within combination therapies.

Clinical Best Practices

  • Adopt a multidisciplinary team approach to deliver holistic care addressing both inflammatory and non-inflammatory symptoms.
  • Regularly assess extra-intestinal manifestations and psychological comorbidities to tailor treatment plans.
  • Incorporate behavioral interventions targeting nutrition, smoking cessation, and stress management to modify disease activity.
  • Leverage digital health tools to support continuous, patient-centered monitoring and care delivery.

References

Original Source(s)

Related Content